VBI Vaccines Inc. (NASDAQ: VBIV)
$0.76
-0.0268 ( -3.41% ) 85.8K
VBI Vaccines Inc is a commercial-stage, the biopharmaceutical company which is engaged in developing next-generation vaccines to address unmet needs in infectious disease and immuno-oncology. The company manufactures Sci-B-Vac product which is a hepatitis B (HBV) vaccine for adults, children, and newborns. Its products include Virus-Like Particle which is vaccine platform which allows for the design of enveloped virus-like particle vaccines that closely mimic the target viruses. The company operates through the single segment being Developing vaccines to address unmet needs in infectious disease and immuno-oncology.
Market Data
Open
$0.76
Previous close
$0.79
Volume
85.8K
Market cap
$21.87M
Day range
$0.74 - $0.79
52 week range
$0.45 - $1.53
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
8-k | 8K-related | 25 | Apr 11, 2024 |
8-k | 8K-related | 27 | Apr 03, 2024 |
8-k | 8K-related | 15 | Apr 02, 2024 |
nt | Quarterly Reports | 1 | Mar 28, 2024 |
8-k | 8K-related | 16 | Feb 14, 2024 |
8-k | 8K-related | 14 | Feb 06, 2024 |
8-k | 8K-related | 12 | Jan 23, 2024 |
8-k | 8K-related | 12 | Jan 11, 2024 |
8-k | 8K-related | 12 | Dec 26, 2023 |
8-k | 8K-related | 12 | Dec 12, 2023 |